Antigenotoxic and anticlastogenic potential of Agaricus bisporus against MMS induced toxicity in human lymphocyte cultures and in bone marrow cells of mice

Egyptian Journal of Medical Human Genetics

Volumn 14, Issue 4, 2013, Pages 395-402

  Ahmad, Md Sultan ^a   Ahmad, Sheeba ^b   Gautam, Brijraj ^a   Afzal, Mohammad ^c  

^a SN (PG) College   (India)

^b DS College   (India)

^c ALIGARH MUSLIM UNIVERSITY   (India)

Author keywords

Agaricus bisporus; Anticarcinogenic; Anticlastogeny; Chromosomal aberration; Replication index; Sister chromatid exchanges

Indexed keywords

AGARICUS BISPORUS EXTRACT; MESYLIC ACID METHYL ESTER; PLANT EXTRACT; UNCLASSIFIED DRUG;

AGARICUS BISPORUS; ALBINO; ANIMAL CELL; ANTICLASTOGENIC ACTIVITY; ANTIGENOTOXIC ACITIVITY; ARTICLE; BONE MARROW CELL; CHROMOSOME ABERRATION; CONTROLLED STUDY; DRUG ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE CULTURE; MOUSE; NONHUMAN; SISTER CHROMATID EXCHANGE;

EID: 84885351188     PISSN: 11108630     EISSN: 20902441     Source Type: Journal    
DOI: 10.1016/j.ejmhg.2013.07.002     Document Type: Article

References (27)

1. Borchers A., Krishnamurthy A., Keen C., Meyers F., Gershwin M. The immunobiology of mushrooms. Exp Biol Med 1999, 233:259-276.
2. Wasser S.P. Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Appl Microbiol Biotech 2002, 60:258-274.
3. Yu S., Weaver V., Martin K., Cantorna M. The effects of whole mushrooms during inflammation. BMC Immunol 2009, 10:12.
4. Poucheret P., Fons F., Rapior S. Biological and pharmacological activity of higher fungi: 20-Year retrospective analysis. Crypt Mycol 2006, 27:311-333.
5. Ajith T.A., Janardhanan K.K. Indian medicinal mushrooms as a source of antioxidant and antitumor agents. J Clin Biochem Nutr 2007, 40:157-162.
6. Sliva D., Jedinak A., Kawasaki J., Harvey K., Slivova V. Phellinus linteus suppresses growth, angiogenesis and invasive behaviour of breast cancer cells through the inhibition of AKT signalling. Brit J Cancer 2008, 98:1348-1356.
7. Dulger B., Ergul C.C., Gucin F. Antimicrobial activity of the macrofungus Lepista nuda. Fitoterapia 2002, 73:695-697.
8. Ahmad M.S., Ahmad S., Ali A., Afzal M. DoesCaesalpinia bonducellaameliorate genotoxicity? Anin vitrostudy in human lymphocyte culture andin vivostudy in Albino mice. Egypt J Med Hum Genet 2013, 14(3):247-257.
9. Tice R., Schneider E.L., Rary J.M. The utilization of BrdU incorporation into DNA for the analysis of cellular kinetics. Exp Cell Res 1976, 102:232-236.
10. Karaman S., Tutem E., Baskan K.S., Apak R. Comparison of total antioxidant capacity and phenolic composition of some apple juices with combined HPLC-CUPRAC assay. Food Chem 2010, 120:1201-1209.
11. Komali A.S., Zheng Z., Shetty K. A mathematical model for the growth kinetics and synthesis of phenolics in oregano (Origanum vulgare) shoot cultures inoculated with Pseudomonas species. Process Biochem 1999, 35:227-235.
12. Tanaka M., Kuei C.W., Nagashima Y., Taguchi T. Application of antioxidative maillrad reaction products from histidine and glucose to sardine products. Nippon Suisan Gakkaishil 1998, 54:1409-1414.
13. Zaidman B.Z., Yassin M., Mahajna J., Wasser S.P. Medicinal mushroom modulators of molecular targets as cancer therapeutics. Appl Microbiol Biotech 2005, 67:453-468.
14. Daba A.S., Ezeronye O.U. Anticancer effect of polysaccharide isolated from higher basidiomyctes mushrooms. Afr J Biotech 2003, 2(12):672-678.
15. Baiba J.G., Elizabeth T.E., Yeh-Chih K., Annette K., Shiuan C. White button mushroom phytochemicals inhibit aromatase activity and breast cancer cell proliferation. J Nutr 2001, 131:3288-3293.
16. Velvicka V., Vashishta A., Saraswat-Ohri S., Velvickova J. Immunolgical effects of yeast- and mushroom-derived beta glucans. J Med Food 2008, 11:615-622.
17. Chen S., Oh S.R., Phung S., Hur G., Ye J.J., Kwok S.L., et al. Anti-aromatase activity of phytochemicals in white button mushrooms (Agaricus bisporus). Cancer Res 2006, 66:12026-12034.
18. Israilides C., Kletsas D., Arapoglou D., Philippoussis A., Pratsinis H., Ebringerová A., et al. In vitro cytostatic and immunomodulatory properties of the medicinal mushroom Lentinula edodes. Phytomedicine 2008, 15:512-519.
19. Gu Y.H., Sivam G. Cytotoxic effect of oyster mushroom Pleurotus ostreatus on human androgen-independent prostate cancer PC-3 cells. J Med Food 2006, 9:196-204.
20. Zhang G., Sun J., Wang H., Ng T. A novel lectin with antiproliferative activity from the medicinal mushroom Pholiota adiposa. Acta Biochim Pol 2009, 56:415-421.
21. Zhao J.K., Wang H.X., Ng T.B. Purification and characterization of a novel lectin from the wild toxic mushroom Inocybe umbrinella. Toxicon 2009, 53:360-366.
22. Shen J., Tanida M., Fujisaki Y., Horii Y., Hashimoto K., Nagai K. Effect of the culture extract of Lentinus edodes mycelia on splenic sympathetic activity and cancer cell proliferation. Auton Neurosci 2009, 145:50-54.
23. Jin C., Kim G., Choi Y. Induction of apoptosis by aqueous extract of Cordyceps militaris through activation of caspases and inactivation of Akt in human breast cancer MDA-MB-231 cells. J Microbiol Biotech 2008, 18:1997-2003.
24. Jose N., Ajith T.A., Janardhanan K.K. Methanol extract of the oyster mushroom, Pleurotus florida, inhibits inflammation and platelet aggregation. Phytoth Res 2004, 18:43-46.
25. Besson A., Dowdy S.F., Roberts J.M. CDK inhibitors: cell cycle regulators and beyond. Dev Cell 2008, 14:159-169.
26. Andrej J., Saliva D. Pleurotus ostreatus inhibits proliferation of human breast and colon cancer cells through p53-dependent as well as p53-independent pathway. Int J Oncol 2008, 33(6):1307-1313.
27. Dotto G.P. P21 (WAF1/Cip1): more than a break to the cell cycle?. Biochim Biophys Acta 2000, 1471:M43-M56.